Physician profile
Fred D Cushner
NPI 1588637938
$4,420,193.31
in general payments reported to CMS, 2019-2025
10 companies · $1.6M in 2025
The $1.6M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $698K · 2020: $379K · 2021: $98K · 2022: $216K · 2023: $554K · 2024: $918K · 2025: $1.6M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.6M · Consulting Fee: $292K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $50K · Travel and Lodging: $38K · Food and Beverage: $9,828 · Honoraria: $7,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,633,132.69 |
| Consulting Fee | $291,625.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $49,525.00 |
| Travel and Lodging | $37,613.16 |
| Food and Beverage | $9,828.22 |
| Honoraria | $7,750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,881,775.86 | 2019-2025 | Journey II, K-15 Pork, Real Intelligence |
| Orthalign INC | $439,649.62 | 2019-2025 | Orthalign Plus |
| Kci USA, INC. | $93,117.42 | 2019-2022 | |
| Acelrx Pharmaceuticals, INC. | $2,000.00 | 2021 | |
| Bioventus LLC | $1,400.00 | 2021 | |
| Bioness INC | $1,050.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $902.50 | 2021-2025 | Persona, Mymobility Platform |
| Medtronic USA, INC. | $207.99 | 2019-2020 | |
| Stryker Corporation | $76.47 | 2021-2025 | Mako |
| Depuy Synthes Sales INC. | $13.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Cushner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.